Current role
Filip Janku
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Filip Janku
The proxy statement of Monte Rosa Therapeutics, Inc. reports total compensation of $1,941,781 for Filip Janku in fiscal 2025, including a base salary of $520,000. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Monte Rosa Therapeutics, Inc. (GLUE)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Monte Rosa Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Ajim Tamboli CFO
- Jennifer Champoux COO
- Sharon Townson CTO
- Philip Nickson General Counsel
- Matthew Bowen Chief Accounting Officer
- Andrew Schiff Board Member
- Anthony M. Manning, Ph.D. Board Member
- Anthony Manning Board Member
- Chandra P. Leo Board Member
- Eric A. Hughes, M.D., Ph.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Monte Rosa Therapeutics, Inc. (GLUE) | M.D., Ph.D. Chief Medical Officer | $520,000 | $1,941,781 |
| 2024 | Monte Rosa Therapeutics, Inc. (GLUE) | M.D., Ph.D. Chief Medical Officer | $500,000 | $1,257,869 |
Recent activity
No call appearances or filed executive changes recorded yet.